Skip to main content
. 2021 Sep 29;9(10):1102. doi: 10.3390/vaccines9101102

Table 2.

Quality assessment of included studies.

Risk of Bias in the Included Rcts Assessed by the Risk of Bias Tool
Selection bias Performance bias Detection bias Attrition bias Reporting bias Other bias Study
Random sequence generation Allocation concealment Blinding of participants and personnel Blinding of outcome assessment Incomplete outcome data Selective reporting Anything else, ideally prespecified
low low low low low low low Han et al., 2021 [19]
low low low low unclear low low Frenck et al., 2021 [20]
Methdological quality in the case series and case reports assessed by Murad et al. checklist
Selection Ascertainment Causality Reporting Study
Does the patient(s) represent(s) the whole experience of the investigator (centre) or is the selection method unclear to the extent
that other patients with similar presentation may not have been reported?
Was the exposure adequately ascertained? Was the outcome adequately ascertained? Were other alternative causes that may explain the observation ruled out? Was there a challenge/rechallenge phenomenon? Was there a dose-response effect? Was follow-up long enough for outcomes to occur? Is the case(s) described with sufficient details to allow other investigators to replicate the research or to allow practitioners make
inferences related to their own practice?
0 1 1 0 N/A N/A 0 0 Revon-Riviere et al., 2021 [21]
0 1 1 0 N/A N/A 0 1 Snapiri et al., 2021 [22]
0 1 1 0 N/A N/A 1 1 Minocha et al., 2021 [23]
0 1 1 0 N/A N/A 1 1 McLean et al., 2021 [24]
0 1 1 1 N/A N/A 0 1 Marshall et al., 2021 [25]
0 1 1 1 N/A N/A 1 1 Schauer et al., 2021 [26]

0 = no; 1 = yes; N/A: Not applicable.